Norovirus Infection
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
VaxartSOUTH SAN FRANCISCO, CA
2 programs2
Norwalk GI.1 VirusPhase 11 trial
VXA-G1.1-NNPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
VaxartVXA-G1.1-NN
VaxartNorwalk GI.1 Virus
Clinical Trials (2)
Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines
Start: Mar 2019Est. completion: Apr 2021
Phase 1Completed
Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model
Start: Oct 2018Est. completion: Nov 2018
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space